World

Human body's protein recycling system fights bacteria like antibiotics: study

Mar 06, 2025

Jerusalem [Israel], March 6: Israeli researchers have discovered a surprising immune defense role of the proteasome, a cellular structure known for degrading and recycling proteins, the Weizmann Institute of Science (WIS) said Wednesday in a statement.
The study, published in Nature, could inspire new strategies against antibiotic-resistant infections, WIS said.
The study found that when breaking down old proteins, the proteasome constantly and regularly releases antimicrobial peptides, which are considered vital components of the body's first line of defense as they attack and kill bacteria, WIS added.
Experiments showed that human cells with active proteasomes effectively controlled bacterial growth, while blocking proteasome activity allowed infections to spread, it said.
In infected mice, proteasome-produced peptides reduced bacteria numbers, decreased tissue damage, and even improved survival rates, performing as effectively as strong antibiotics in clinical use, it noted.
The team identified over 270,000 potential antibacterial peptides hidden within 92 percent of human proteins, opening a new frontier for developing tailored therapies to strengthen immune defenses in high-risk patients, such as those with cancer or weakened immune systems, according to the statement.
Source: Xinhua News Agency

More news

Lincoln Pharmaceuticals Ltd Targets Revenue of Rs. 1,000 Crore Within the Next Three Years

Ahmedabad (Gujarat) [India], November 14: Lincoln Pharmaceuticals Limited (BSE: 531633, NSE: LINCOLN), one of India's leading healthcare companies, has reported a consolidated net profit of Rs. 20.01 crore for the Q2 FY 2025-26. Total income for the quarter ended September 2025 was reported at Rs. 170.60 crore, and EBITDA was reported at Rs. 32.66 crore. Shareholders at the 31st Annual General Meeting (AGM) approved a dividend of Rs. 1.80 per share (18%) for the FY 2024-25.

Nov 14, 2025